Status:
COMPLETED
Validation of HC250 and HC240 Series.
Lead Sponsor:
Fisher and Paykel Healthcare
Conditions:
Obstructive Sleep Apnea (OSA)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is designed to determine the effectiveness of two different CPAP devices. One a standard CPAP which has the ability to store comprehensive compliance and efficacy data and the second a auto...
Detailed Description
All patients with suspected obstructive sleep apnea presenting at the Auckland Hospital Sleep Laboratory and referred for either a split-night or full night diagnostic study, will be offered participa...
Eligibility Criteria
Inclusion
- Inclusions criteria:
- AHI \> 15 on the diagnostic night or portion of the split night study.
- ≥18yrs of age
- Exclusion criteria:
- Significant Central Apnea
- CHF
- Co-existing obesity related hypoventilation
- Inability to give informed consent
- Patient intolerance to CPAP
- Anatomical or physiological conditions making CPAP therapy inappropriate.
- Less than 3 hours in the titration period
- Under Land Transport New Zealand (LTNZ) investigation
Exclusion
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00739011
Start Date
August 1 2008
End Date
November 1 2008
Last Update
December 9 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Auckland Hospital Sleep laboratory
Auckland, New Zealand
2
Auckland Physiology Sleep Lab
Auckland, New Zealand